- Home
- About
- Find staff
- Miriam Bollmann
Miriam Bollmann
Researcher
Department of Rheumatology and Inflammation Research-
Combination treatment with anti-RANKL and antibiotics for preventing joint destruction in septic
arthritis.
Zhicheng Hu, Meghshree Deshmukh, Anders Jarneborn, Miriam Bollmann, Carmen Corciulo, Pradeep Kumar Kopparapu, Abukar Ali, Mattias N D Svensson, Cecilia Engdahl, Rille Pullerits, Majd Mohammad, Tao Jin
JCI insight - 2025 -
Transforming growth factor beta induces interleukin-11 expression in
osteoarthritis
Juliane Lokau, Miriam Bollmann, Yvonne Garbers, Eugen Feist, Christoph H. Lohmann, Jessica Bertrand, Christoph Garbers
CYTOKINE - 2025 -
Methotrexate promotes the release of granulocyte-macrophage colony-stimulating factor from rheumatoid arthritis fibroblast-like synoviocytes via autocrine interleukin-1
signaling
Beatrice Bergström, Tilia Selldén, Miriam Bollmann, Mattias N D Svensson, Anna-Karin Hultgård Ekwall
ARTHRITIS RESEARCH & THERAPY - 2024 -
Local Immune Activation and Age Impact on Humoral Immunity in Mice, with a Focus on IgG
Sialylation.
Priti Gupta, Tibor Sághy, Miriam Bollmann, Tao Jin, Claes Ohlsson, Hans Carlsten, Carmen Corciulo, Cecilia Engdahl
Vaccines - 2024 -
Immunomodulatory Nanoparticles for Modulating Arthritis
Flares
Wade T Johnson, David McBride, Matthew Kerr, Anders Nguyen, Martina Zoccheddu, Miriam Bollmann, Xiaofu Wei, Ryan M Jones, Wei Wang, Mattias N D Svensson, Nunzio Bottini, Nisarg J Shah
ACS nano - 2023